Becker Hewes
Chief Tech/Sci/R&D Officer bei BLUEPRINT MEDICINES CORPORATION
Vermögen: 4 Mio $ am 31.03.2024
Profil
Becker Hewes ist Chief Medical Officer bei Blueprint Medicines Corp. In seiner früheren Karriere war Dr. Hewes Chief Medical Officer bei Repertoire Immune Medicines, Inc. und Executive Director-Translational Clinical Oncology bei Novartis Institutes for Biomedical Research, Inc. Er promovierte an der Georgetown University School of Medicine und erwarb einen Bachelor-Abschluss an der Vanderbilt University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 07.03.2024 | 46 281 ( 0,08% ) | 4 Mio $ | 31.03.2024 |
Aktive Positionen von Becker Hewes
| Unternehmen | Position | Beginn |
|---|---|---|
| BLUEPRINT MEDICINES CORPORATION | Chief Tech/Sci/R&D Officer | 11.01.2021 |
Ehemalige bekannte Positionen von Becker Hewes
| Unternehmen | Position | Ende |
|---|---|---|
Repertoire Immune Medicines, Inc.
 Repertoire Immune Medicines, Inc. Miscellaneous Commercial ServicesCommercial Services Repertoire Immune Medicines, Inc. operates as a clinical-stage biotechnology company. It focuses on the immune system to prevent, treat, and cure cancer, autoimmune disorders, and infectious diseases. The company was founded by Noubar Afeyan and is headquartered in Cambridge, MA. | Chief Tech/Sci/R&D Officer | 01.05.2020 |
Novartis Institutes for Biomedical Research, Inc.
 Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01.02.2017 |
Ausbildung von Becker Hewes
| Vanderbilt University | Undergraduate Degree |
| Georgetown University School of Medicine | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| BLUEPRINT MEDICINES CORPORATION | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Novartis Institutes for Biomedical Research, Inc.
Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA. | Commercial Services |
Repertoire Immune Medicines, Inc.
Repertoire Immune Medicines, Inc. Miscellaneous Commercial ServicesCommercial Services Repertoire Immune Medicines, Inc. operates as a clinical-stage biotechnology company. It focuses on the immune system to prevent, treat, and cure cancer, autoimmune disorders, and infectious diseases. The company was founded by Noubar Afeyan and is headquartered in Cambridge, MA. | Commercial Services |
